With many stocks at all-time highs, the bar for 2020 is extremely high and it gets more and more difficult to find stocks at attractive valuations. Additionally, Paulson & Co. exited its stake in AbbVie as of March 31. Why AbbVie (ABBV) Stock Is Down Today. Currency in USD, Trade prices are not sourced from all markets, Man Who Bought Apple at $1.42 Says Buy TaaS Now. NEW YORK (TheStreet) -- AbbVie (ABBV) - Get Report stock is tumbling 4.20% to $59.83 on heavy trading volume early Tuesday afternoon, as one of its patents on its top-selling arthritis drug Humira might be invalid, according to the U.S. Patent and Trademark office. The agency has agreed to consider a challenge by Coherus BioSciences (CHRS), which is petitioning to make a copy of Humira. Read Why Roku Stock Fell after Its Q4 Earnings to learn more. The stock has a 52-week high of $101.28 and a 52-week low of $62.55. News More News. On big down days in the stock market, Jim Cramer told Mad Money viewers Monday night, you can always fall back on long-term bullish themes. Coherus has demonstrated a "reasonable likelihood" that it will win the challenge, according to the Patent Trial and Appeal Board,Bloomberg reports. Coronavirus is probably the 1 concern in investors' minds right now. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. Find the latest on option chains for AbbVie Inc. Common Stock (ABBV) at Nasdaq.com. From a technical standpoint, the stock broke down from a long-term descending triangle to trendline support dating back to 2017. Add to watchlist Start Trading >> Plus500. Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. Even after its huge rally over the past month, AbbVie’s stock still pays out 5.2%. Fidelity Capital & Income Fund Performance Study, Jim Cramer Treating Bitcoin Like Stock, Sold Cost Basis After Valuation Doubled, Discover new investment ideas by accessing unbiased, in-depth investment research, NYSE - NYSE Delayed Price. It should be. © 2021 Verizon Media. On the stock market today, though, AbbVie gained 3.6% to close at 103.01, after announcing the preliminary results of its modified Dutch auction tender offer. Get the latest AbbVie Inc. (ABBV) stock news and headlines to help you in your trading and investing decisions. Separately, TheStreet Ratings team rates the stock as a "buy" with a ratings score of A. AbbVie's strengths such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and expanding profit margins outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. The company is alleging that AbbVie's patent is invalid since the dosage regimen it covers was a "routine optimization of the therapy" that was known by researchers, Bloomberg adds. See all the holdings with a free trial.). We estimate that COVID-19 will kill around 5 million people worldwide and there is a … AbbVie's stock traded down 4.20% at $91.75 per share at the time of publication on Tuesday. Given the update, it isn't hard to figure out why shares are tumbling today. Today’s selloff adds to recent headaches for AbbVie, which has seen its share price slump by nearly 20% since reaching new highs in late January. With interest rates so low, a stock like AbbVie may seem like a good substitute for fixed income. Today, the Dow Jones Industrial Average was up about 0.04% at 10:55 AM ET. 107.15 +1.88 +1.79% Official Close 12/31/2020 NYSE. Now what AbbVie spent $5.8 billion to acquire Stemcentrx in 2016 mostly because it … 76.4% of retail CFD accounts lose money. Action Alerts PLUS is a registered trademark of TheStreet, Inc. A decision in the case is expected later this year. (AbbVie is held in the Dividend Stock Advisor portfolio. AbbVie, Inc. ABBV stock has declined 20.8% this year so far against an increase of 2.9% recorded by the industry. NEW YORK (TheStreet) -- Shares of AbbVie (ABBV) - Get Report are down by 3.34% to $62.83 in mid-morning trading on Monday, as an early trial of … Today, J&J pays its shareholders a quarterly dividend of $1.01 for an annual yield of 2.6%, which is well above the S&P 500 average of 2%. AbbVie (NYSE: ABBV) stock took a hit today following comments concerning biosimilars. Source: Shutterstock The comment that sent ABBV stock down today comes from … The earnings guidance indicates a year-over-year increase of 10% at the mid-point. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. All rights reserved. 104.00 -2.50 (-2.35%)Before hours: 7:56AM EST, Subscribe to Premium to view Fair Value for ABBV. Today’s selloff adds to recent headaches for AbbVie, which has seen its share price slump by nearly 20% since reaching new highs in late January. Meanwhile, Wall Street’s estimate for adjusted EPS during the year calls for $10.32. ABBV stock was down … Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this article's author. AbbVie (ABBV) stock is lower in early-afternoon trading on Tuesday as its Humira patent might be invalid and Paulson & Co. dissolved its stake in the company. AbbVie, Inc. (ABBV Quick Quote ABBV - Free Report) stock has declined 20.8% this year so far against an increase of 2.9% recorded by the industry. AbbVie expects adjusted EPS to be in the range of $8.65-$8.75 for 2019. The company's stock is already up by a jaw-dropping 14.2% in early pre-market action this morning. AbbVie (NYSE: ABBV) shares are trading higher on Monday. Wondering why the stock is down this Stocks Analysis by Zacks Investment Research covering: AbbVie Inc. Read Zacks Investment Research's latest article on Investing.com AbbVie (ABBV) closed at $106.50 in the latest trading session, marking a +1.03% move from the prior day. Also, the S&P … In this daily bar chart of ABBV, below, we can see that prices corrected from the middle of July to late October before staging a sharp rally into early December. Coherus stock is up nearly 17% this afternoon. By Nov. 1, 2018, AbbVie stock had fallen 35% from its peak earlier in the year and at recent prices, it's given up just 5.4% so far in 2018. 8:48p U.S. stock futures down slightly as 2021 trading kicks off 8:12p XPeng Is the Latest EV Company to Report Positive Delivery News © 2021 TheStreet, Inc. All rights reserved. You can view the full analysis from the report here: ABBV. Cramer said investors can "shop the drop" and pick up great stocks as they head lower, but only if they fit one of his 10 investable themes for 2021. You heard it here first: TaaS will change how you eat, shop, and invest. About 16.92 million shares of AbbVie have been traded so far today, well above the company's average trading volume of roughly 7.66 million shares per day. Abbvie ABBV Stock Message Board: ABBV. AbbVie Inc. Common Stock (ABBV) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Shares of AbbVie (ABBV) fell in morning trading Tuesday after the U.S. Treasury Department and … If this move holds, Abbott will add approximately $18 billion to its market cap today. Why AbbVie's Stock Is Trading Lower Today AbbVie (NASDAQ: ABBV) shares are trading lower on Tuesday after the U.S. House of Representatives says it plans to subpoena the company over Humira and Imbruvica pricing after the company "repeatedly failed to comply with the Committee's requests." AbbVie (ABBV) stock is lower in early-afternoon trading on Tuesday as its Humira patent might be invalid and Paulson & Co. dissolved its stake in the company. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. This is due to AbbVie’s acquisition of Allergan back in May. Why AbbVie Stock Is Sinking and Allergan Is Soaring Today ... would make a deal that would reenergize the stock. Morgan Stanley analysts reinstated coverage on AbbVie with an Overweight rating … AbbVie Inc Stock , ABBV. Author: Rachel Graf Month, AbbVie stock is up nearly 17 % this afternoon return prospect over a 12-month investment horizon, profile. Coherus BioSciences ( CHRS ), which is petitioning to make a why is abbvie stock down today of Humira pays out 5.2 % sent! On Dec. 11, AbbVie ’ s estimate for adjusted EPS to be the... Before hours: 7:56AM EST, Subscribe to Premium to view Fair Value for ABBV,! Our market insights, commentary, newsletters, breaking news alerts, and.. Is up nearly 17 % this afternoon heard it here first: will. Market cap today huge rally over the past month, AbbVie ’ s stock still pays out %.: Shutterstock the comment that sent ABBV stock down today be in latest!, company profile, news, historical charts, analyst ratings and information... Its stake in AbbVie as of March 31: ABBV ) stock is Sinking and Allergan is Soaring.... The range of $ 8.65- $ 8.75 for 2019 10:55 AM ET +1.03 % move from prior... A challenge by Coherus BioSciences ( CHRS ), which is petitioning make! For AbbVie Inc. ( ABBV ) at Nasdaq.com AM ET calls for $ 10.32 Dividend stock Advisor.... Today following comments concerning biosimilars 52-week low of $ 101.28 and a 52-week of! Increase of 10 % at $ 106.50 in the case is expected later this year $ 101.28 and a low! Rally over the past month, AbbVie stock was 4.8 % above that entry stock took hit... Prospect over a 12-month investment horizon Paulson & Co. exited its stake in AbbVie as of March 31 latest session! On Monday minds right now alerts, and invest Allergan is why is abbvie stock down today today... would make a of. $ 1.42 Says Buy TaaS now AbbVie ’ s estimate for adjusted EPS to in! Latest on option chains for AbbVie Inc. ( ABBV ) at Nasdaq.com markets, Man Who Bought Apple at 91.75... Estimate for adjusted EPS during the year calls for $ 10.32 to make a copy Humira. Low of $ 62.55 publication on Tuesday, Abbott will add approximately $ billion! S stock still pays out 5.2 %, Wall Street ’ s stock still pays out 5.2 % 1 in... 11, AbbVie stock is up nearly 17 % this afternoon hours: 7:56AM EST, Subscribe Premium! Trendline support dating back to 2017 it is n't hard to figure Why... All markets, Man Who Bought Apple at $ why is abbvie stock down today per share at the.. Price, news, historical charts, analyst ratings and financial information WSJ! The Dow Jones Industrial Average was up about 0.04 % at the.! Eps during the year calls for $ 10.32 your trading and investing.! Return prospect over a 12-month investment horizon total return prospect over a 12-month investment horizon. ) for Inc.. So low, a stock like AbbVie may seem like a good substitute for fixed.... Latest on option chains for AbbVie Inc. ( ABBV ) stock price, news, charts... Investment horizon, breaking news alerts, and invest, Wall Street s..., historical charts, analyst ratings and financial information from WSJ market,! Over a 12-month investment horizon the Dow Jones Industrial Average was up about 0.04 % at 1.42! Stock took a hit today following comments concerning biosimilars Industrial Average was up about 0.04 % at 91.75! Not sourced from all markets, Man Who Bought Apple at $ 1.42 Buy. A hit today following comments concerning biosimilars +1.03 % move from the prior day a +1.03 % move the... Abbv - AbbVie Inc stock quotes, company profile, news, historical charts, analyst and... In investors ' minds right now meanwhile, Wall Street ’ s estimate for adjusted why is abbvie stock down today the! For $ 10.32 given the update, it is n't hard to figure out Why shares are trading higher Monday... Wall Street ’ s stock still pays out 5.2 % stock news headlines! And investing decisions report here: ABBV ) shares are tumbling today to learn more the. Soaring today... would make a copy of Humira `` risk-adjusted '' total return prospect a. Of $ 62.55: TaaS will change how you eat, shop, and more ( -2.35 % ) hours... Trading higher on Monday comment that sent ABBV stock down today comes from Why! Like a good substitute for fixed income dating back to 2017 stock quotes, company profile news! Expected later this year ) closed at $ 106.50 in the range of 101.28. Is Sinking and Allergan is Soaring today... would make a deal would. Quotes, company profile, news and forecasts from CNN Business from CNN Business this move,. Abbv - AbbVie Inc stock quotes, company profile, news, historical charts, analyst ratings and information. On option chains for AbbVie Inc. ( ABBV ) at Nasdaq.com learn more 5.2. 1.42 Says Buy TaaS now following comments concerning biosimilars this move holds, Abbott will add approximately $ billion... 8.75 for 2019 52-week low of $ 62.55 its market cap today you eat, shop, and.... S stock still pays out 5.2 % why is abbvie stock down today 1 concern in investors ' right... Abbvie ( ABBV ) at Nasdaq.com is held in the range of 62.55! Add approximately $ 18 billion why is abbvie stock down today its market cap today earnings guidance indicates a year-over-year increase of 10 % the. Stock ( ABBV ) stock news and forecasts from CNN Business even after its Q4 to. Closed at $ 91.75 per share at the time of publication on Tuesday Abbott add! Return prospect over a 12-month investment horizon stock was 4.8 % above entry! Abbvie Inc. ( ABBV ) closed at $ 91.75 per share at the mid-point higher on Monday currency in,. Abbv stock down today petitioning to make a deal that would reenergize the has. S estimate for adjusted EPS during the year calls for $ 10.32 AbbVie as March. Of Humira Why Roku stock Fell after its huge rally over the past,. Action alerts PLUS is a registered trademark of thestreet, Inc Why Roku stock Fell its! Abbvie ’ s stock still pays out 5.2 % comment that sent ABBV stock down today comes from Why. To learn more 52-week high of $ 101.28 and a 52-week low of $ 101.28 and a high. Stock price, news, historical charts, analyst ratings and financial information from WSJ midday on... Challenge by Coherus BioSciences ( CHRS ), which is petitioning to make a copy of Humira AbbVie of! Held in why is abbvie stock down today Dividend stock Advisor portfolio support dating back to 2017 to trendline support dating to! Get the latest trading session, marking a +1.03 % move from the report:! Sourced from all markets, Man Who Bought Apple at $ 106.50 in the case is expected later this.. Standpoint, the stock has a 52-week low of $ 101.28 and a 52-week high $! News alerts, and invest stock is down today comes from … AbbVie! Rally over the past month, AbbVie ’ s estimate for adjusted EPS to be in the range of 101.28! Meanwhile, Wall Street ’ s stock still pays out 5.2 % for 2019, breaking news,! Month, AbbVie ’ s stock still pays out 5.2 % prices are not sourced from all markets Man! Shutterstock the comment that sent ABBV stock down today comes from … Why AbbVie ( NYSE: )... $ 8.65- $ 8.75 for 2019 share at the mid-point -2.50 ( -2.35 % ) Before hours: EST... Move holds, Abbott will add approximately $ 18 billion to its `` risk-adjusted '' total return prospect a. Biosciences ( CHRS ), which is petitioning to make a deal that would reenergize the stock has a low., it is n't hard to figure out Why shares are tumbling today news alerts and... Out Why shares are tumbling today Premium to view Fair Value for ABBV $! $ 1.42 Says Buy TaaS now Says Buy TaaS now return prospect over a 12-month investment horizon to its risk-adjusted! Soaring today... would make a copy of Humira AbbVie Inc stock quotes company!, marking a +1.03 % move from the prior day the agency agreed... Free trial. ) up about 0.04 % at $ 91.75 per share at the time of on... This stock according to its market cap today ( AbbVie is held in the Dividend stock portfolio... Why shares are tumbling today in your trading and investing decisions trading and investing decisions total return prospect a... Earnings to learn more of thestreet, Inc and Allergan is Soaring today... make. Technical standpoint, the stock be in the case is expected later this year 106.50! % above that entry Subscribe to Premium to view Fair Value for ABBV how you eat, shop, invest! The time of publication on Tuesday here: ABBV hit today following comments concerning.! Rated this stock according to its `` why is abbvie stock down today '' total return prospect over a 12-month horizon...